Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tim Vogels awarded two major grants from the Wellcome Trust and the European Research Council

Research

Congratulations to Associate Professor Tim Vogels (Department of Physiology, Anatomy & Genetics), who has been awarded a Wellcome Trust Senior Research Fellowship and an ERC Consolidator grant.

Tim Vogels has been awarded a Wellcome Trust Senior Research Fellowship on "Exploring the spatiotemporal dynamics of memory” and an ERC Consolidator grant on "Machine learning assisted exploration of synaptic plasticity." These highly prestigious awards will fund his lab for the next five years.

Tim has been part of the CNCB since 2013, funded by a Sir Henry Dale Fellowship of the Wellcome Trust and the Royal Society, and his research group is also part of the neurotheory initiative at the University of Oxford. 

Read more (Department of Physiology, Anatomy & Genetics website)

Similar stories

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Three ways virtual reality could transform mental health treatment

General Research

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.